首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Breast cancer family history and allele-specific DNA methylation in the legacy girls study
Authors:Hui-Chen Wu  Catherine Do  Irene L Andrulis  Esther M John  Mary B Daly  Saundra S Buys
Institution:1. Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY;2. Department of Environmental Health Sciences, Mailman School of Public Health of Columbia University, New York, NY;3. John Theurer Cancer Center, Hackensack University Medical Center, Hackensack NJ;4. Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario;5. Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;6. Cancer Prevention Institute of California, Fremont CA;7. Department of Health Research &8. Policy (Epidemiology), and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA;9. Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA;10. Department of Medicine and, Huntsman Cancer Institute, University of Utah Health Sciences Center, UT
Abstract:Family history, a well-established risk factor for breast cancer, can have both genetic and environmental contributions. Shared environment in families as well as epigenetic changes that also may be influenced by shared genetics and environment may also explain familial clustering of cancers. Epigenetic regulation, such as DNA methylation, can change the activity of a DNA segment without a change in the sequence; environmental exposures experienced across the life course can induce such changes. However, genetic-epigenetic interactions, detected as methylation quantitative trait loci (mQTLs; a.k.a. meQTLs) and haplotype-dependent allele-specific methylation (hap-ASM), can also contribute to inter-individual differences in DNA methylation patterns. To identify differentially methylated regions (DMRs) associated with breast cancer susceptibility, we examined differences in white blood cell DNA methylation in 29 candidate genes in 426 girls (ages 6–13 years) from the LEGACY Girls Study, 239 with and 187 without a breast cancer family history (BCFH). We measured methylation by targeted massively parallel bisulfite sequencing (bis-seq) and observed BCFH DMRs in two genes: ESR1 (Δ4.9%, P = 0.003) and SEC16B (Δ3.6%, P = 0.026), each of which has been previously implicated in breast cancer susceptibility and pubertal development. These DMRs showed high inter-individual variability in methylation, suggesting the presence of mQTLs/hap-ASM. Using single nucleotide polymorphisms data in the bis-seq amplicon, we found strong hap-ASM in SEC16B (with allele specific-differences ranging from 42% to 74%). These findings suggest that differential methylation in genes relevant to breast cancer susceptibility may be present early in life, and that inherited genetic factors underlie some of these epigenetic differences.
Keywords:Breast cancer family history  DNA methylation  mQTL  white blood cells  childhood and adolescent cohort
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号